CF Bankshares Inc.: Form 10-Q for the period ended Sep 30, 2022
Filed with the SEC on Nov 9, 2022 and accepted by EDGAR at Nov 9, 2022, 12:05 ET.
Management's discussion and analysis
As filed, 1,372 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(a) None.
(b) Not applicable.
(c) The following table provides information concerning purchases of the Holding Company’s shares of common stock made by or on behalf of the Company or any “affiliated purchaser” as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended, during the three months ended September 30, 2022.
| Period | Total number of common shares purchased | Average price paid per common share | Total number of common shares purchased as part of publicly announced plans or programs | Maximum number of common shares that may yet be purchased under the plans or programs | |
|---|---|---|---|---|---|
| July 1, 2022 through July 31, 2022 | 1,143 | (1) | 20.55 | - | - |
| August 1, 2022 through August 31, 2022 | 83,434 | (2) | 21.00 | - | - |
| September 1, 2022 through September 30, 2022 | - | - | - | - | |
| Total | 84,577 | $20.99 | - |
(1) Reflects shares of common stock surrendered to the Company for the payment of taxes upon the vesting of restricted stock .
(2) Reflects 83,333 shares of common stock purchased by the Company in a block purchae from a non-affiliated shareholder in a privately-negotiated transaction authorized and approved by the Board of Directors and 101 shares of common stock surrendered to the Company for the payment of taxes upon the vesting of restricted stock.
Risk factors
As filed, 319 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There were no material changes to the risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, as supplemented by “Item 1A. Risk Factors” of Part II of the Quarterly Reports on Form 10-Q filed with the SEC for the quarterly periods ended March 31, 2022 and June 30, 2022.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Interest expense | 3 months2022-07-01 to 2022-09-30 | $4.7m | us-gaap:InterestExpense |
| Interest expense | 9 months2022-01-01 to 2022-09-30 | $10.2m | us-gaap:InterestExpense |
| Income tax | 3 months2022-07-01 to 2022-09-30 | $1.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-01-01 to 2022-09-30 | $3.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-07-01 to 2022-09-30 | $4.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-01-01 to 2022-09-30 | $13.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-07-01 to 2022-09-30 | $0.65 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-01-01 to 2022-09-30 | $2.06 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-07-01 to 2022-09-30 | $0.66 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-01-01 to 2022-09-30 | $2.11 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-07-01 to 2022-09-30 | 6,547,791 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-01-01 to 2022-09-30 | 6,549,691 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-01-01 to 2022-09-30 | $33.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-01-01 to 2022-09-30 | $798.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2022-01-01 to 2022-09-30 | $835.0k | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2022-09-30 | $198.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2022-09-30 | $1.76bn | us-gaap:Assets |
| Total liabilities | At period end2022-09-30 | $1.63bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-09-30 | $134.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001070680-22-000040. Last ingested by Listed: Nov 13, 2026, 01:50 ET. Listed shows no prices and gives no investment advice.